Superior vena cava syndrome caused by chemotherapy-induced fibrosis.

Abstract

We report a case of a 51-year old man with small cell lung cancer who developed superior vena cava syndrome due to obstruction of the superior vena cava at the junction of the brachiocephalic vein by a fibrotic band, 2 months after completing six cycles of chemotherapy with cisplatin and etoposid. Superior vena cava syndrome caused by chemotherapy-induced pulmonary fibrosis should be kept in mind during follow-up.

• Authors: H M Turk, C Camci, S Buyukberber, B Tuncozgur, C Sivrikoz, L Elbeyli, I Sari
• Journal: Journal of chemotherapy (Florence, Italy) (J Chemother) Vol. 14 Issue 4 Pg. 417-9 (Aug 2002) ISSN: 1120-009X [Print] England
• PMID: 12420862 (Publication Type: Case Reports, Journal Article)

Chemical References

• Etoposide
• Cisplatin

Topics

• Antineoplastic Combined Chemotherapy Protocols (adverse effects)
• Carcinoma, Small Cell (drug therapy, pathology)
• Cisplatin (administration & dosage)
• Etoposide (administration & dosage)
• Fibrosis
• Follow-Up Studies
• Humans
• Lung Neoplasms (drug therapy, pathology)
• Magnetic Resonance Imaging
• Male
• Middle Aged
• Superior Vena Cava Syndrome (chemically induced, diagnosis)
• Vena Cava, Superior (drug effects, pathology)